CONTEXT: Peer reviewed paper reviewing standard treatments for non-infectious uveitis, which is a major cause of vision loss. This data review includes analysis from both RCT and RWR studies to Continue Reading
CONTEXT: Latest update (8 April 2021) from LEEM describing the role of the QP PV | Must read! IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: Continue Reading
CONTEXT: A comprehensive summary of multiple studies | Low key press release with potentially big impact in the real world IMPACT: Medium READ TIME: 3 mins Quality Level Mean [1 Continue Reading
CONTEXT: When the world falls apart, we still (thankfully) have studies focusing on the stuff (viruses) that impact us when we aren’t focusing on COVID | This is a retrospective Continue Reading
CONTEXT: Prospective observational study in releasing remitting multiple sclerosis (RRMS) with a relatively old treatment showing a fairly content and stable patient population in Germany | Study conducted between 2015 Continue Reading
CONTEXT: Commercial announcement of a significant acquisition in the RWD space | Is this the biggest deal we will see this year or is there more to come? IMPACT: Medium Continue Reading
CONTEXT: This retrospective analysis of an at-home monitoring system gives hope for suffers of age-related macular degeneration (AMD) | The large sale analysis of US patients showed the system could Continue Reading
CONTEXT: Publication from the analysis of the first 500 patients enrolled in a pulmonary arterial hypertension (PAH) registry showed promising treatment results in stabilising or reducing their 1-year mortality risk Continue Reading
CONTEXT: Publication of an RWE study in type 2 diabetes patients treated with SGLT2 and GLP1- receptor antagonists showing a long term reduction in risk of coronary heart disease | Continue Reading
CONTEXT: Relatively small scale RWE study (102 patients) on the variation in biomarker testing in NSCLC patients in the Netherlands. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 Continue Reading
